Which medications can increase appetite in patients with depression?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Medications That Increase Appetite in Depression

Mirtazapine is the single most effective antidepressant for stimulating appetite in depressed patients, producing consistent weight gain through direct histamine H1-receptor antagonism in the hypothalamus. 1, 2

First-Line Recommendation: Mirtazapine

  • Mirtazapine at 30 mg daily produces mean weight gains of 1.9 kg at 3 months and 2.1 kg at 6 months, with approximately 80% of patients experiencing weight gain. 3, 1
  • The appetite-stimulating effect begins within the first weeks of therapy and persists throughout treatment, making it ideal when both depression and poor appetite require simultaneous treatment. 1
  • Standard dosing starts at 15 mg at bedtime, titrating to 30-45 mg based on clinical response. 1
  • Mirtazapine is particularly valuable when depression coexists with insomnia, decreased weight, or decreased appetite, as demonstrated in head-to-head trials against nortriptyline and venlafaxine. 2

Alternative Agents With Appetite-Stimulating Properties

Tricyclic Antidepressants

  • Amitriptyline produces the greatest weight gain among tricyclics (approximately 1.8 kg in controlled trials), driven by histamine H1-receptor blockade and marked increases in preference for sweets. 1, 4
  • Nortriptyline also causes significant weight gain, though less than amitriptyline. 1
  • Imipramine appears weight-neutral and does not increase appetite, making it unsuitable for this indication. 1
  • Desipramine is the least likely tricyclic to induce carbohydrate craving and increased appetite. 5

SSRIs: Paroxetine

  • Paroxetine causes the greatest long-term weight gain among all SSRIs, exceeding the impact of sertraline, fluoxetine, and other selective serotonin reuptake inhibitors. 1
  • The weight-gain effect emerges primarily during maintenance treatment (beyond 12 weeks) and may be underestimated in short-term trials. 1

Agents to Avoid When Appetite Stimulation Is Desired

  • Fluoxetine and sertraline produce modest weight loss during acute treatment (4-12 weeks) and remain weight-neutral long-term, making them inappropriate when appetite stimulation is the goal. 1
  • Bupropion consistently causes weight loss (~1.3 kg) by suppressing appetite and food cravings through dopamine and norepinephrine reuptake inhibition. 1, 2
  • Bupropion is most effective for hypersomnia, increased weight, increased appetite, or fatigue—the opposite symptom profile from patients needing appetite stimulation. 2
  • Citalopram and escitalopram show no clinically significant effect on body weight or appetite. 1
  • Venlafaxine and duloxetine cause only slight weight increases with long-term use and are not reliable appetite stimulants. 1

Clinical Decision Algorithm

  1. If depression coexists with poor appetite, weight loss, or insomnia: Prescribe mirtazapine 15 mg at bedtime, titrating to 30 mg. 1, 2

  2. If mirtazapine is contraindicated or not tolerated: Consider amitriptyline (if tricyclics are appropriate) or paroxetine (if an SSRI is required), recognizing that both carry higher side-effect burdens than mirtazapine. 1, 4

  3. If the patient has hypersomnia, fatigue, or already-increased appetite: Avoid mirtazapine entirely and select bupropion, which addresses these specific symptoms. 2

  4. Monitor weight within the first 2-4 weeks: Mirtazapine's appetite effect begins early, allowing rapid assessment of therapeutic benefit. 1

Common Pitfalls and Caveats

  • Do not prescribe appetite stimulants (megestrol acetate, dronabinol, corticosteroids) for antidepressant-induced appetite suppression in otherwise healthy patients—these agents are reserved for cancer-related cachexia or end-of-life care. 1
  • Weight gain from improved appetite due to depression remission must be distinguished from medication-induced weight gain; mirtazapine produces both effects simultaneously. 1
  • Excessive weight gain is the most common cause of antidepressant discontinuation in patients receiving appetite-stimulating agents, occurring in approximately 50% of patients on tricyclics. 4
  • In dementia patients, mirtazapine should only be used when depression coexists with weight loss—it should not be prescribed solely for weight gain in the absence of depression. 3, 1
  • Histamine H1-receptor antagonism is the primary mechanism for appetite stimulation with mirtazapine and tricyclics, not sedation or metabolic effects. 1, 5

References

1
Guideline

Weight and Sexual Function Considerations in Antidepressant Selection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4
Research

Weight gain. A side-effect of tricyclic antidepressants.

Journal of affective disorders, 1984

5
Research

Carbohydrate craving and increased appetite associated with antidepressant therapy.

Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1988

Related Questions

When are stimulant medications appropriate for treating depression, and what are their expected effects, benefits, and risks?
Can depression reduce nocturnal penile tumescence (morning erections)?
What is the recommended initial treatment—including psychotherapy and first‑line medication—for a 15‑year‑old 10th‑grade student with depressive symptoms, no confirmed autism diagnosis, who wishes to start therapy and possibly medication?
Can tingling and burning sensations be psychosomatic manifestations of high anxiety?
What are the recommended treatment options for anxiety in older adults, including non‑pharmacologic therapies and appropriate pharmacologic agents?
What is the recommended daily folic acid supplementation dose for pregnant women with epilepsy?
What is the recommended titration schedule for divalproex sodium (Depakote)?
What is the appropriate treatment for mild pulmonary edema due to slight fluid overload in the lungs?
Can I give a muscle relaxant to an otherwise healthy adult with non‑fractured rib pain?
In a patient with acute serous otitis whose ear culture shows heavy growth of Staphylococcus aureus (oxacillin‑susceptible, inducible clindamycin resistance) and light growth of Pseudomonas putida, is amoxicillin alone an appropriate treatment?
Is Pueraria (kudzu root) safe for patients with chronic kidney disease?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.